Index
1 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | P | Q | R | S | T | U | V | W
1
- 1D09C3
A
- Annual General Meeting
- Annual Shareholders’ Meeting
-
- Apprenticeship position
- Assets
- Auditor’s report
B
- Balance Sheet
- Balance Sheet
- BHQ 880
- Business Development
C
- Cash flows
- Cash flow statement
- Capital expenditure
- CD20
- CD38
- CD38
- Change of control
- Committees of the Supervisory Board
-
- Competition
- Convertible Bonds
- Corporate Communications
- Corporate Governance Report
-
- Corporate Social Responsibility
-
- Cost by expenditure type
- Costs of goods sold
- Credit rating
- Currency risk
D
- Declaration of conformity
-
- Declarations persuant to § 315 para 4 of the German Commercial Code (HGB)
-
- Directors’ dealings
-
- Dividend
E
- Earnings per share
- EBIT
- Employees
- Environmental protection
-
- Equity
F
- Financial analysis
- Financial calendar 2009
- Financial targets
- Forecast
G
- GM-CSF
- Goodwill
H
I
- Impairment test
- Income taxes
- Intellectual property
- ISO9001:2000
- ISO13485:2006
K
- Key figures
L
- Letter to the Shareholders
-
- Liabilities
- Liquidity
L
- Macroeconomic development
-
- Management Board
- Management of the Group
-
- Management report
- Manufacturing license
- Market
- Market capitalization
- Marketing expenses
- Milestone payments
- MOR103
- MOR202
N
- Net income
- Non-operating items
O
- Operating expenses
- Operating leases
- Operating profit
- Operational targets
- Opportunities
- Outlook
p
- Patents
- Pensions
- Performance-based management and control
-
- Personnel cost
- Procurement
- Production
- Proprietary pipeline
- Provisions
Q
- Quality assurance
- Quality management
R
- R1450
- Remuneration report
- Remuneration, Supervisory Board
-
- Remuneration, equity-based
-
- Remuneration, Management Board
-
- Report of the Supervisory Board
-
- Research and development
-
- Research and development expenses
-
- Research Antibodies
- Responsibility statement
- Revenues
- Revenue recognition
- Risks
- Risk management
S
- Sales, general and administrative expenses
-
- Segment reporting
- Segment Research Antibodies
- Segment Therapeutic Antibodies
- Shareholder structure
- Shareholdings, Management and Supervisory Boards
-
- Share price development
- Social Responsibility
- Statement of operations
- Statements of changes in shareholders’ equity
- Stock-based compensation
- Stock options
- Subsequent events
- Subsidiaries
- Supervisory Board
- Sustainability
T
- Taxes
- Trading volumes
- Trading volumes
W
- WACC